Latest filing published 03 Aug 2023 for Nexien Biopharma, INC..
Insider track record
Robert I. Goldfarb: trading record in brief
Robert I. Goldfarb is a declared insider at 2 companies; the most frequent names are Nexien Biopharma, Inc. and Andrx Corp /DE/. Over a trading history stretching from 1 January 2006 to 25 July 2023, the count stands at 13 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 August 2023, the filings show a share grant in Nexien Biopharma, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert I. Goldfarb
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 sharesCommon StockSEC:0001214659-23-010690:1
- 250,000 sharesCommon StockSEC:0001214659-23-010690:0
- 250,000 sharesCommon StockSEC:0001214659-23-000783:0
- 250,000 sharesCommon StockSEC:0001214659-22-012399:0
- 250,000 sharesCommon StockSEC:0001214659-22-011127:0
- 2,400 shares@ US$0.3860.4% of flowCommon StockSEC:0001214659-18-003952:0
- 2,400 shares@ US$0.2539.6% of flowCommon stockSEC:0001214659-18-001544:0
- 644,227 sharesCommon StockSEC:0001214659-17-007049:0
- 5,003.2 shares@ US$25.00Andrx Group Common StockSEC:0001209191-06-057954:0
- 37,594 shares@ US$25.00Andrx Group Common StockSEC:0001209191-06-057954:1
- 13,000 shares0Andrx Group Common StockSEC:0001209191-06-014811:0
- 763 shares@ US$16.48Andrx Group Common StockSEC:0001209191-06-000502:0
12 of 12 declarations
